NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
SYSCHEM (INDIA) LTD. (BSE: 531173)
531173 Technical Analysis
1.5
As on 24th Dec 2024 531173 SHARE Price closed @ 53.91 and we RECOMMEND Sell for LONG-TERM with Stoploss of 54.93 & Buy for SHORT-TERM with Stoploss of 52.27 we also expect STOCK to react on Following IMPORTANT LEVELS. |
531173SHARE Price
Open | 53.00 | Change | Price | % |
High | 54.50 | 1 Day | 1.66 | 3.18 |
Low | 52.10 | 1 Week | 7.32 | 15.71 |
Close | 53.91 | 1 Month | 7.32 | 15.71 |
Volume | 101586 | 1 Year | 3.52 | 6.99 |
52 Week High 73.90 | 52 Week Low 44.00 |
BSE INDIA Most Active Stocks
532822 | 7.47 | -0.13% |
532411 | 0.41 | 0.00% |
517001 | 0.09 | 12.50% |
511700 | 1.01 | -0.98% |
512149 | 0.88 | 0.00% |
511389 | 7.25 | -2.42% |
534690 | 7.65 | 4.79% |
532775 | 2.04 | -0.97% |
531328 | 1.05 | 0.96% |
532648 | 19.80 | -0.60% |
BSE INDIA Top Gainers Stocks
BSE INDIA Top Losers Stocks
531173 Daily Charts |
531173 Intraday Charts |
Whats New @ Bazaartrend |
531173 Free Analysis |
|
531173 Important Levels Intraday
RESISTANCE | 58.53 |
RESISTANCE | 57.05 |
RESISTANCE | 56.13 |
RESISTANCE | 55.22 |
SUPPORT | 52.60 |
SUPPORT | 51.69 |
SUPPORT | 50.77 |
SUPPORT | 49.29 |
531173 Target May 2025
4th UP Target | 0 |
3rd UP Target | 0 |
2nd UP Target | 0 |
1st UP Target | 0 |
1st DOWN Target | 0 |
2nd DOWN Target | 0 |
3rd DOWN Target | 0 |
4th DOWN Target | 0 |
531173 Weekly Target
4th UP Target | 0.00 |
3rd UP Target | 0.00 |
2nd UP Target | 0.00 |
1st UP Target | 0.00 |
1st DOWN Target | 0.00 |
2nd DOWN Target | 0.00 |
3rd DOWN Target | 0.00 |
4th DOWN Target | 0.00 |
531173 Target2025
4th UP Target | 114 |
3rd UP Target | 93.49 |
2nd UP Target | 80.82 |
1st UP Target | 68.14 |
1st DOWN Target | 31.98 |
2nd DOWN Target | 19.3 |
3rd DOWN Target | 6.63 |
4th DOWN Target | -13.88 |
SYSCHEM (INDIA) LTD. ( BSE INDIA Symbol : 531173 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
531173 Other Details
Segment | EQ | |
Market Capital | 126011336.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers - Major | |
Offical website | > echo $website ; ?> |
531173 Address
![]() |
531173 Latest News
531173 Business Profile
Syschem (India) Limited manufactures and sells active pharmaceuticals ingredients (APIs), intermediates, bulk drugs, and specialty chemicals in India. Its APIs/intermediates include amoxycillin trihydrate, ampicillin trihydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, cephalexin, cefixime, and cefadroxil. The company also offers generic products in tablet, softgel/capsule, injection, syrup/suspension, and herbal and personal care forms. In addition, it engages in the distillation of specialty solvents, such as DMF, acetonitrile, ethyl acetate, and THF; and contract manufacturing business. The company was incorporated in 1993 and is based in Chandigarh, India. Address: SCO 825, NAC Manimajra, Chandigarh, India, 160101
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service